Fact CheckerSign in

NCT06234332Recruiting

Peking University Birth Cohort in Weifang (PKUBC-WF)

Peking University Birth Cohort in Weifang

Source: ClinicalTrials.gov · Last updated 24 Nov 2025

Brief summary (registry, in English)

The PKUBC-WF is a prospective cohort study carried out in Weifang city of Shandong, China. The primary aim of this study is to investigate the short-term and long-term effects of pre-pregnant and prenatal exposure on maternal and child health. Data are collected regarding environmental, nutritional and lifestyle exposures as well as short-term and long-term health outcomes of mothers and their children from birth to before 18 years old. Biological samples including peripheral blood, urine, placenta, umbilical cord, cord blood, and faeces are also collected.

Status (registry)
Recruiting
Study type
Observational
Enrollment
2800 (estimated)
First submitted
23 Jan 2024
Start date
1 Feb 2024
Primary completion date
31 Dec 2026
Lead sponsor
Peking University
NCT number
NCT06234332

What you commit to

  • Study type: Observational
  • Planned participants: 2800
  • From 1 Feb 2024 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Participants who cannot communicate normally.

Who the study is looking for

  • Pregnant woman
    • Pregnant women, 6-13\^+6 gestational weeks
    • Resided in Weifang in the past half years and have no plan to move out after delivery
    • Pregnant women who plan to have antenatal care and delivery in Weifang maternal\&Child Hospital.
    • Pregnant women who is willing to participate in this study with informed consent
  • Pregnant woman's husband
    • His wife was eligible for enrollment
    • He is the biological father of the child (his wife's current pregnancy)
    • Pregnant women's husband who is willing to participate in this study with informed consent
  • Offspring 4. Children born to pregnant women who met the inclusion criteria after enrolling in this study.
    • 5\. Before the age of 8 years, his/her mother provided written informed consent. 6. After 8 years old, he/she agreed to continue this study and signed the informed consent.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Peking University
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.